Sign in

or Register now

SchizophreniaConnection.com

See all of our health sites at www.HealthCentral.com
Sunday, October, 12, 2008

Paul Ballas's SharePosts Relating to: "Alert"

A New Indication for Abilify

Recently, the medication Abilify (aripiprazole) was approved by the FDA for the treatment of schizophrenia in the adolescent population aged 13 - 17. This is a significant development in the treatment of schizophrenia, and I thought it would be interesting to explain how this medication received this new indication after being on... Read moreChevron

Add comment  |  No Comments

Coronary Heart Disease Plays a Major Role in the Life Expectancy of People with Schizophrenia

Recently, a reader made a comment about life expectancy in people who have schizophrenia. This has been a subject of considerable debate for years in psychiatry. The sad truth is that people with the illness die sooner than the general population. Some research estimates that schizophrenia reduces life expectancy by 20%. Now the reasons for... Read moreChevron

Ask a Question

Get answers from our experts and community members.

Answer a Question

Is there any legal way a schizophrenic patient can be forced to take a diagnostic medical test?

Answer This View all questions >
Free Newsletter
Get weekly updates, news alerts and more on Schizophrenia and related health conditions.